Advanced Accelerator Applications USA Inc. was awarded a $194,773.86 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15. The firm fixed price order is for the delivery of LUTATHERA and PLUVICTO radiopharmaceuticals to the agency through December 31, 2022 to support patient care. No set-aside designation was applied to this contract, which will...
This federal contract award to Advanced Accelerator Applications USA Inc. is for the initial four patient doses of the Lutathera radiopharmaceutical treatment for neuroendocrine cancer. The $144,400.00 firm fixed price purchase order was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 23 and has a completion date of September 30, 2018. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical company that...
This federal contract award to Advanced Accelerator Applications USA Inc. is for the delivery of the radiopharmaceutical drug LUTATHERA for direct patient care. The contract, awarded by the Veterans Integrated Service Network (VISN) 12 of the U.S. Department of Veterans Affairs (VA), has a ceiling value of $157,041.40 and a period of performance ending on August 30, 2024. The contract was awarded on December 7, 2023 and is a Delivery Order under the Pharmaceuticals and Drugs Federal Supply...
This contract award to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer, is for the delivery of the radiopharmaceutical product LUTATHERA to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price delivery order, valued at $326,532.69, was issued on December 17, 2018 with a completion date of April 28, 2020. The contract does not have a set-aside designation. Advanced Accelerator...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $157,041 firm fixed price delivery order to Advanced Accelerator Applications USA Inc. for the provision of LUTATHERA nuclear medicine. The order was placed against the Pharmaceuticals and Drugs Federal Supply Schedule, contract number FSS-61-IB, with performance to take place in Millburn, New Jersey by December 30, 2023. No set-aside designation was specified. Advanced...
This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceutical products. The $145,125.64 firm fixed price delivery order is for the cancer drug LUTATHERA. The contract does not have a set-aside designation. Advanced Accelerator Applications USA Inc. has several additional federal contracts and blanket...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $157,041 firm fixed price delivery order to Advanced Accelerator Applications USA Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is for the provision of LUTATHERA radiopharmaceuticals to the VA medical center in Millburn, New Jersey, with performance required by August 31, 2024. No set-aside designation was used for this award. Advanced...
The Department of Veterans Affairs Veterans Health Administration awarded a $157,041 delivery order to Advanced Accelerator Applications USA Inc. for the drug LUTATHERA. The order was issued against the company's Pharmaceuticals and Drugs contract (FSS-61-IB) through the General Services Administration Multiple Award Schedule program. Performance will take place in Millburn, New Jersey over approximately two months from mid-July through early September 2023. The firm fixed price contract...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price delivery order to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals, to provide 3 doses of Lutetium Dotatate. The $112,221.42 contract was awarded on June 3, 2021, with a completion date of December 31, 2021. This order was placed through the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. Advanced Accelerator Applications USA...
The Department of Veterans Affairs Veterans Health Administration awarded a $296,967.82 firm fixed price delivery order to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The order is for 16 doses of the radioligand therapy drug LUTATHERA (Lutetium Lu 177) to treat 4 patients. The contract does not utilize any set-asides and has a completion date of September 30, 2019. Advanced Accelerator Applications USA Inc. holds several federal...